offerings encompass end-to-end capabilities such as assay development, reader technology, app and cloud integration, contract manufacturing, medical affairs, and quality and regulatory support. The company’s assay development spans lateral flow, ELISA, and microfluidic platforms, supporting various specimen types and detection formats. Manufacturing operations include ISO 13485-certified production of reagents, test kits, and reader devices under controlled conditions, facilitating seamless design transfer and scalable output.